Cost-benefit analysis of the integrated pharmaceutical supply chain information service after the establishment of the Korean Pharmaceutical Information Service

被引:0
作者
Kim, Myojeong [1 ]
Lee, GeunWoo [1 ]
Hwang, Yungi [1 ]
Kim, Tae Hyun [2 ]
Kim, Dong-Sook [1 ]
机构
[1] Dept Res Hlth Insurance Review & Assessment Serv, Wonju, South Korea
[2] Yonsei Univ, Coll Med, Seoul, South Korea
关键词
cost-benefit analysis; pharmaceutical supply chain; pharmaceutical information service; Korea; benefit; DRUG; TRADE;
D O I
10.3389/fphar.2022.925287
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The Korean Pharmaceutical Information Service (KPIS) was established in October 2007 to increase the transparency of the pharmaceutical supply chain by integrating relevant information. This study aimed to describe the KPIS program and perform a cost-benefit analysis of the KPIS. Methods: We conducted a cost-benefit analysis based on cost savings in terms of National Health Insurance (NHI). The outcome measures were the net financial benefit and benefit-cost ratio over the 12 years since the establishment of the KPIS. The cost estimate included the costs of labor and business operations, the development of an information entry system, and office maintenance. Financial benefits were defined as savings resulting from the implementation of the program based on KPIS data. Social benefits were defined as the prevention of recalled medicines from entering the supply chain and the decrease in inventory and disposal. Results: The KPIS clearly resulted in a net financial benefit, saving 37.2 million USD, which was 2.6 times higher than the cost of implementation. While the benefit-cost ratio was less than one during the first period, it exceeded 3.4 during the second period. After calculating and integrating social benefits, the net benefit increased to 571.6 million USD, and the benefit-cost ratio was 24.8. A sensitivity analysis of the annual benefit showed that the net benefit varied from a low of -1.5 million USD to a high of 24.7 million USD according to the program implementation year. Conclusion: The establishment of the KPIS and a system for collecting information on the pharmaceutical supply chain showed meaningful financial and social benefits when compared to the input cost. Since no other countries have an integrated pharmaceutical information system that incorporates all information from production to administration, the example of the KPIS can provide a precedent for other countries.
引用
收藏
页数:8
相关论文
共 17 条
  • [1] Aitken M., 2016, PHARM POLICY LAW, V18, P55, DOI DOI 10.3233/PPL-160432
  • [2] Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste?
    Alshemari, Abdullah
    Breen, Liz
    Quinn, Gemma
    Sivarajah, Uthayasankar
    [J]. PHARMACY, 2020, 8 (04)
  • [3] [Anonymous], 1988, DEV IMPL NAT DRUG PO
  • [4] Barchetti U., 2010, Proceedings of the 5th International Conference on Computer Sciences and Convergence Information Technology (ICCIT 2010), P58, DOI 10.1109/ICCIT.2010.5711029
  • [5] Barlas Stephen, 2011, P T, V36, P203
  • [6] Brechtelsbauer Erich D, 2016, Hosp Pharm, V51, P493, DOI 10.1310/hpj5106-493
  • [7] Enhanced UHF RFID Tags for Drug Tracing
    Catarinucci, Luca
    Colella, Riccardo
    De Blasi, Mario
    Patrono, Luigi
    Tarricone, Luciano
    [J]. JOURNAL OF MEDICAL SYSTEMS, 2012, 36 (06) : 3451 - 3462
  • [8] Coustasse Alberto, 2010, J Hosp Mark Public Relations, V20, P100, DOI 10.1080/15390942.2010.493369
  • [9] Critical Success Factors of a Drug Traceability System for Creating Value in a Pharmaceutical Supply Chain (PSC)
    da Silva, Ronaldo Brito
    de Mattos, Claudia Aparecida
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (11)
  • [10] HIRA, 2021, NATL HLTH INSURANCE